Skip to content

Use of Shvetkaraviradya Taila in Eczema(Vicharchika)

Randomised Control Trial of Shevtkarviradi Taila in Vicharchika with Special Reference to Eczema

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040062
Enrollment
70
Registered
2022-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Sponsors

Laxmi Nagarthawar Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of vicharchika patients in between age group 16 to 60 years patients will be selected irrespective of cast sex religion and socioeconomical status patients having chronicity not more than 5 years patients having controlled hypertension patients who are willing to participate and ready to give written consent patients who are not participated in any other trial or last 6 month

Exclusion criteria

Exclusion criteria: Patients having Diabetes Mellitus patients having varicose vein Patients with Psoriasis Leprosy or other skin disease patients having any other uncontrolled systemic disorders and chronicity more than 5 year patients who are not willing to participate and not ready to give written Consent Patients regular corticosteroid therapy for long term

Design outcomes

Primary

MeasureTime frame
To Study the Relief in Signs and Symptoms of Vicharchika before Treatment and after Tratment of Local Application of Shvetkarviradi Taila and Durvadya Taila. Timepoint: In 10 days

Secondary

MeasureTime frame
To Review and Study literature of Vicharchika To Study and Review literature of EczemaTimepoint: 18 months

Countries

India

Contacts

Public ContactVd Jayant D Gulhane

Government Ayurved College and hospital Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026